Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: ...
Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...
A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting ...
Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER), has also been particularly outspoken against mRNA vaccines. Prasad said it was a “wise decision” to ...
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...
NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...
Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their ...
Venture financing for messenger ribonucleic acid (mRNA)-based innovator vaccines declined by 82% from $510m in 2023 to $90m ...
RFK Jr. canceled $500 million of funding for research on mRNA vaccine technology. Anadolu/Getty Images At a Sept. 4, 2025, hearing before the Senate Finance Committee, Health and Human Services ...
Over the last year, Noubar Afeyan has watched Cambridge-based Moderna go from perhaps the world’s most celebrated company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results